Author: Rövekamp, M., von Glinski, A., Volkenstein, S., Dazert, S., Sengstock, C., Schildhauer, T.A. and Breisch, M.
World Neurosurgery, 2022
Here, the authors of the study aimed to demonstrate the feasibility of isolation and cultivation of olfactory stem cells (OSCs) for the treatment of spinal cord injury (SCI). The CytoSMART Lux2 was used to monitor OSCs over the span of 72 hours, observing changes in morphology as well as cell migration. The results of this study demonstrate successful differentiation of OSCs into neural lineage, indicating the establishment of an appropriate method of OSC handling and highlighting the potential of the olfactory mucosa for autologous cell therapeutic treatments.
